Operator

Good day, ladies and gentlemen. Thank you for joining Genomma Lab's First Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this meeting is being recorded and will be available for replay from the Investor Relations section of Genomma's website following the call.

I'll now turn the call over to Christianne Ibanez, Genomma's Head of Investor Relations. Please go ahead.

Christianne Ibañez
Head of Investor Relations

Thank you, and welcome, everyone. On today's call are Marco Sparvieri, Chief Executive Officer; and Antonio Zamora, Chief Financial Officer.

Before we get started, I'd like to remind you that the remarks today will include forward-looking statements, such as the company's financial guidance and expectations including long-term objectives and forecasts as well as expectations regarding Genomma's business, products, strategies, demand, and markets. These statements are subject to risks and uncertainties that could cause actual results to differ materially. They are also based on assumptions as of today, and the company undertakes no obligation to update them as a result of new information or future events.

Let me now turn the call over to Mr. Marco Sparvieri.

Marco Sparvieri
Chief Executive Officer

Thank you, Chris, and thank you, everyone, for joining our first quarter 2026 earnings call. Let me open with where we stand. We are executing on our growth initiatives, expanding distribution, opening up new routes in the traditional channel, stepping up in-store execution, and increasing new investment. This execution is delivering early signs of market share recovery in Mexico, which is encouraging.